Tags : Intravacc

PharmaShots Weekly Snapshot (Jun 01-05, 2020)

Tuba Khan June 8, 2020

1. Novartis Reports Results of Enerzair Breezhaler (QVM149) in P-IIIb ARGON Study to Treat Uncontrolled Asthma Published: Jun 04, 2020 | Tags: Novartis, Reports, Enerzair Breezhaler, QVM149, P-IIIb, ARGON Study, Treat, […]readmore

Biotech COVID-19

Intravacc and EpiVax Collaborate to Develop an Emerging Vaccine for

Tuba Khan June 3, 2020

Shots: Intravacc signs an agreement with EpiVax for the development of novel vaccine against COVID-19, based on Intravacc’s Outer Membrane Vesicles (OMV) technology platform The collaboration will combine Intravacc’s OMV […]readmore

Tags : Intravacc

PharmaShots Weekly Snapshot (Jun 01-05, 2020)

Intravacc and EpiVax Collaborate to Develop an Emerging Vaccine for

Latest Posts

PharmaShots Weekly Snapshots (November 15 – 19, 2021)

Jazz’ Sunosi (solriamfetol) Receives NICE Recommendation for the Treatment of Excessive Daytime Sleepiness Caused by Narcolepsy

Antengene’s Selinexor (ATG-010) Receives NMPA’s IND Approval for P-I/II SWATCH Study to Treat Non-Hodgkin Lymphoma

Daiichi Sankyo Reports Results of Quizartinib in P-III QuANTUM-First Trial for the Treatment of FLT3-ITD Positive AML

Company

Tags : Intravacc

PharmaShots Weekly Snapshot (Jun 01-05, 2020)

Intravacc and EpiVax Collaborate to Develop an Emerging Vaccine for

Latest Posts

PharmaShots Weekly Snapshots (November 15 – 19, 2021)

Jazz’ Sunosi (solriamfetol) Receives NICE Recommendation for the Treatment of Excessive Daytime Sleepiness Caused by Narcolepsy

Antengene’s Selinexor (ATG-010) Receives NMPA’s IND Approval for P-I/II SWATCH Study to Treat Non-Hodgkin Lymphoma

Daiichi Sankyo Reports Results of Quizartinib in P-III QuANTUM-First Trial for the Treatment of FLT3-ITD Positive AML

Categories

Related Topics

Company